InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Larsen Glenn R., Director. Director active across 2 companies, notably Anika Therapeutics, Inc.. Aggregated, 6 disclosures have been published. History available since 16 June 2021. The latest transaction was disclosed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Larsen Glenn R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
14,164 shares0Common StockSEC:0001171843-25-004070:0
5,771 shares0Common StockSEC:0001171843-24-003908:0
6,500 shares0Common StockSEC:0001171843-23-003960:0
7,954 shares0Common StockSEC:0001171843-22-004300:0
4,172 shares0Common StockSEC:0001171843-21-004428:0
2,361 sharesCommon StockSEC:0001171843-16-007718:0
6 of 6 declarations
About Larsen Glenn R.
Glenn R. Larsen is a Board Member at Anika Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the company's initiatives. As a board member, he ensures that Anika meets its performance and innovation objectives.
